Foundayo’s experimental treatment for obstructive sleep apnea met its primary endpoint in a late-stage clinical trial, signaling a potential shift for patients who fail to tolerate standard CPAP machines.
The company confirmed the results early Tuesday. Patients receiving the drug showed a statistically significant reduction in their apnea-hypopnea index—the standard metric for tracking breathing interruptions during sleep—compared to those on a placebo.
For the millions of people who struggle with Continuous Positive Airway Pressure (CPAP) therapy, these results offer a rare alternative. Many patients abandon masks due to discomfort, leaving their condition untreated and increasing risks for hypertension, stroke, and cardiovascular disease.
Foundayo’s data suggests the drug works by targeting the underlying neuromuscular mechanisms that cause throat muscles to collapse during sleep. While the company has yet to release the full, peer-reviewed dataset, the initial readout indicates a consistent benefit across diverse patient demographics.
Safety remains the primary focus for regulators. In the trial, common side effects included mild gastrointestinal distress and headaches, though researchers noted that few participants dropped out of the study due to adverse events.
The medical community has been watching this space closely. Previous attempts to develop pharmacological treatments for sleep apnea have largely stalled, often failing to move the needle on long-term breathing stability. Foundayo’s success here clears a path for a formal filing with the FDA.
If approved, the drug would likely become the first non-mechanical, first-line treatment for moderate-to-severe cases. For now, the company is preparing to present the complete findings at the upcoming American Thoracic Society conference.
The real test, however, lies in the long-term data. While these results show promise for nightly symptom management, physicians will be looking for sustained efficacy over months—not just weeks—before moving this into standard clinical practice.
